机构:[1]Division of Liver surgery and NHC Key Lab of Transplant Engineering and Immunology, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[3]Department of Laboratory Medicine, the West China Second University Hospital, Sichuan University, Chengdu 610041, China[4]West China-California Research Center for Predictive Intervention Medicine, Chengdu 610041, China[5]Regenerative Medical Research Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[6]Proteomics-Metabolomics Platform, Core facilities, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[7]Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[8]Lung Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[9]SCMPA Key Laboratory for Quality Research and Control of Chemical Medicine, Chengdu Institute for Drug Control, Chengdu 610041, China[10]Department of Ophthalmology, The Third People’s Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, China[11]Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[12]Division of Abdominal Tumor Multimodality Treatment Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院
This work is supported by the National Natural Science Foundation of China (82173727, 82172731, 82204684, 82402718 and 81102366), and the Natural Science Foundation of Sichuan Province (2025ZNSFSC0785).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|1 区医学
小类|1 区药学2 区化学:综合
最新[2025]版:
大类|1 区医学
小类|1 区药学2 区化学:综合
第一作者:
第一作者机构:[1]Division of Liver surgery and NHC Key Lab of Transplant Engineering and Immunology, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China[2]Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Division of Liver surgery and NHC Key Lab of Transplant Engineering and Immunology, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China[2]Sichuan Provincial Engineering Laboratory of Pathology in Clinical Application, West China Hospital, Sichuan University, Chengdu 610041, China[6]Proteomics-Metabolomics Platform, Core facilities, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
Tao Ze,Li Yingying,Huang Yunchuan,et al.Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects[J].Journal Of Controlled Release : Official Journal Of The Controlled Release Society.2025,383:113835.doi:10.1016/j.jconrel.2025.113835.
APA:
Tao Ze,Li Yingying,Huang Yunchuan,Hu Liqiang,Wang Shisheng...&Yang Hao.(2025).Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects.Journal Of Controlled Release : Official Journal Of The Controlled Release Society,383,
MLA:
Tao Ze,et al."Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects".Journal Of Controlled Release : Official Journal Of The Controlled Release Society 383.(2025):113835